{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:40Z","timestamp":1761129580830},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Armed Forces Health Surveillance Center\u2013"},{"name":"Department of Defense Global Emerging Infections System"},{"name":"Consortium for National Health Research (","award":["RCDG-2012\u2013032"],"award-info":[{"award-number":["RCDG-2012\u2013032"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,24]]},"DOI":"10.1093\/infdis\/jiz027","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T20:12:24Z","timestamp":1547237544000},"page":"1969-1979","source":"Crossref","is-referenced-by-count":7,"title":["Correlation Between Malaria-Specific Antibody Profiles and Responses to Artemisinin Combination Therapy for Treatment of Uncomplicated Malaria in Western Kenya"],"prefix":"10.1093","volume":"219","author":[{"given":"Geoffrey","family":"Odhiambo","sequence":"first","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"},{"name":"Maseno University School of Physical and Biological Sciences Zoology Department, Maseno, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Bergmann-Leitner","sequence":"additional","affiliation":[{"name":"Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moureen","family":"Maraka","sequence":"additional","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine N L","family":"Wanjala","sequence":"additional","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"},{"name":"Maseno University School of Physical and Biological Sciences Zoology Department, Maseno, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Duncan","sequence":"additional","affiliation":[{"name":"Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Waitumbi","sequence":"additional","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Andagalu","sequence":"additional","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter G Z O","family":"Jura","sequence":"additional","affiliation":[{"name":"Maseno University School of Physical and Biological Sciences Zoology Department, Maseno, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[{"name":"Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelina","family":"Angov","sequence":"additional","affiliation":[{"name":"Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhards R","family":"Ogutu","sequence":"additional","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"},{"name":"Kenya Medical Research Institute, Nairobi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Kamau","sequence":"additional","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"},{"name":"Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ochiel","sequence":"additional","affiliation":[{"name":"Department of Emerging and Infectious Diseases, United States Army Medical Research Directorate\u2013Africa, Kenya Medical Research Institute\/Walter Reed Project , Kisumu"},{"name":"Maseno University School of Physical and Biological Sciences Zoology Department, Maseno, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"2019052411105870600_CIT0001","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"key":"2019052411105870600_CIT0002","doi-asserted-by":"crossref","DOI":"10.30875\/50d27d62-en","volume-title":"World malaria report 2017","author":"World Health Organization","year":"2017"},{"key":"2019052411105870600_CIT0003","doi-asserted-by":"crossref","first-page":"e4383","DOI":"10.1371\/journal.pone.0004383","article-title":"Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends","volume":"4","author":"Ghani","year":"2009","journal-title":"PLoS One"},{"key":"2019052411105870600_CIT0004","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4269\/ajtmh.11-0595","article-title":"Heterogeneity and changes in inequality of malaria risk after introduction of insecticide-treated bed nets in Macha, Zambia","volume":"88","author":"Norris","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"2019052411105870600_CIT0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM200101253440403","article-title":"A molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimd\u00e9","year":"2001","journal-title":"N Engl J Med"},{"key":"2019052411105870600_CIT0006","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"2019052411105870600_CIT0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0031182015001249","article-title":"Immunity to malaria in an era of declining malaria transmission","volume":"143","author":"Fowkes","year":"2016","journal-title":"Parasitology"},{"key":"2019052411105870600_CIT0008","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4269\/ajtmh.2003.69.558","article-title":"Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria","volume":"69","author":"Djimd\u00e9","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"2019052411105870600_CIT0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-3024.2006.00808.x","article-title":"Immune effector mechanisms in malaria","volume":"28","author":"Marsh","year":"2006","journal-title":"Parasite Immunol"},{"key":"2019052411105870600_CIT0010","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1073\/pnas.1001323107","article-title":"A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray","volume":"107","author":"Crompton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019052411105870600_CIT0011","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/IAI.01585-07","article-title":"Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria","volume":"76","author":"Osier","year":"2008","journal-title":"Infect Immun"},{"key":"2019052411105870600_CIT0012","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/cid\/cit556","article-title":"Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria","volume":"57","author":"Rono","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019052411105870600_CIT0013","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0031182011001144","article-title":"Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?","volume":"138","author":"Sutherland","year":"2011","journal-title":"Parasitology"},{"key":"2019052411105870600_CIT0014","doi-asserted-by":"crossref","first-page":"ofw229","DOI":"10.1093\/ofid\/ofw229","article-title":"Artemether-lumefantrine and dihydroartemisinin-piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda","volume":"4","author":"Taylor","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2019052411105870600_CIT0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pt.2007.11.008","article-title":"Antimalarial dosing regimens and drug resistance","volume":"24","author":"Barnes","year":"2008","journal-title":"Trends Parasitol"},{"key":"2019052411105870600_CIT0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1473-3099(09)70322-6","article-title":"Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria","volume":"10","author":"Rogerson","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2019052411105870600_CIT0017","first-page":"449","article-title":"Why is it that antimalarial drug treatments do not always work?","volume":"92","author":"White","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"2019052411105870600_CIT0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2875-6-72","article-title":"The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya","volume":"6","author":"Amin","year":"2007","journal-title":"Malar J"},{"key":"2019052411105870600_CIT0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0972-9062.117475","article-title":"Malaria vector population dynamics in highland and lowland regions of western Kenya","volume":"50","author":"Omukunda","year":"2013","journal-title":"J Vector Borne Dis"},{"key":"2019052411105870600_CIT0020","volume-title":"Parasite clearance estimator","author":"Worldwide Antimalarial Resistance Network","year":"2012"},{"key":"2019052411105870600_CIT0021","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-10-339","article-title":"Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator","volume":"10","author":"Flegg","year":"2011","journal-title":"Malar J"},{"key":"2019052411105870600_CIT0022","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fmicb.2014.00625","article-title":"Antibody and B cell responses to Plasmodium sporozoites","volume":"5","author":"Dups","year":"2014","journal-title":"Front Microbiol"},{"key":"2019052411105870600_CIT0023","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/icb.2009.27","article-title":"The future for blood-stage vaccines against malaria","volume":"87","author":"Richards","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"2019052411105870600_CIT0024","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(03)00077-X","article-title":"Development and pre-clinical analysis of a Plasmodium falciparum merozoite surface protein-1(42) malaria vaccine","volume":"128","author":"Angov","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"2019052411105870600_CIT0025","doi-asserted-by":"crossref","first-page":"e12294","DOI":"10.1371\/journal.pone.0012294","article-title":"Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei","volume":"5","author":"Bergmann-Leitner","year":"2010","journal-title":"PLoS One"},{"key":"2019052411105870600_CIT0026","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/IAI.73.4.2109-2115.2005","article-title":"Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.","volume":"73","author":"Hillier","year":"2005","journal-title":"Infect Immun"},{"key":"2019052411105870600_CIT0027","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2007.03.012","article-title":"Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-na\u00efve adults at the Walter Reed Army Institute of Research","volume":"25","author":"Polhemus","year":"2007","journal-title":"Vaccine"},{"key":"2019052411105870600_CIT0028","doi-asserted-by":"crossref","first-page":"e111020","DOI":"10.1371\/journal.pone.0111020","article-title":"IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice","volume":"9","author":"Schwenk","year":"2014","journal-title":"PLoS One"},{"key":"2019052411105870600_CIT0029","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/1475-2875-13-410","article-title":"Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1\u03b11 using ELISA and a magnetic bead-based duplex assay (MAGPIX\u00ae-Luminex) in a Senegalese meso-endemic community","volume":"13","author":"Perraut","year":"2014","journal-title":"Malar J"},{"key":"2019052411105870600_CIT0030","volume-title":"Emergency response to artemisinin resistance in the greater Mekong subregion: regional framework for action 2013\u20132015","author":"World Health Organization","year":"2013"},{"key":"2019052411105870600_CIT0031","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.1615875114","article-title":"Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort","volume":"114","author":"Ataide","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019052411105870600_CIT0032","doi-asserted-by":"crossref","first-page":"e0162524","DOI":"10.1371\/journal.pone.0162524","article-title":"Genetically determined response to artemisinin treatment in Western Kenyan Plasmodium falciparum parasites","volume":"11","author":"Chebon","year":"2016","journal-title":"PLoS One"},{"key":"2019052411105870600_CIT0033","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2875-13-33","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study","volume":"13","author":"Ogutu","year":"2014","journal-title":"Malar J"},{"key":"2019052411105870600_CIT0034","doi-asserted-by":"crossref","first-page":"ofw217","DOI":"10.1093\/ofid\/ofw217","article-title":"Parasite clearance and artemether pharmacokinetics parameters over the course of artemether-lumefantrine treatment for malaria in human immunodeficiency virus (HIV)-infected and HIV-uninfected Ugandan children","volume":"3","author":"Kajubi","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2019052411105870600_CIT0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1475-2875-10-263","article-title":"Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration","volume":"10","author":"Morris","year":"2011","journal-title":"Malar J"},{"key":"2019052411105870600_CIT0036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.1994.tb04271.x","article-title":"Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria","volume":"37","author":"Na Bangchang","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"2019052411105870600_CIT0037","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12936-018-2294-5","article-title":"A systematic and prospectively validated approach for identifying synergistic drug combinations against malaria","volume":"17","author":"KalantarMotamedi","year":"2018","journal-title":"Malar J"},{"key":"2019052411105870600_CIT0038","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4269\/ajtmh.2005.73.222","article-title":"Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection","volume":"73","author":"John","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2019052411105870600_CIT0039","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1016\/j.vaccine.2013.06.042","article-title":"A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria","volume":"31","author":"Murungi","year":"2013","journal-title":"Vaccine"},{"key":"2019052411105870600_CIT0040","doi-asserted-by":"crossref","first-page":"e3557","DOI":"10.1371\/journal.pone.0003557","article-title":"Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults","volume":"3","author":"Dent","year":"2008","journal-title":"PLoS One"},{"key":"2019052411105870600_CIT0041","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jmedent\/43.2.200","article-title":"Population dynamics of malaria vectors in western Kenya highlands","volume":"43","author":"Ndenga","year":"2006","journal-title":"J Med Entomol"},{"key":"2019052411105870600_CIT0042","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1038\/srep19472","article-title":"Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity","volume":"6","author":"Yman","year":"2016","journal-title":"Sci Rep"},{"key":"2019052411105870600_CIT0043","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/infdis\/jir222","article-title":"Effect of the pre-erythrocytic candidate malaria vaccine RTS,S\/AS01E on blood stage immunity in young children","volume":"204","author":"Bejon","year":"2011","journal-title":"J Infect Dis"},{"key":"2019052411105870600_CIT0044","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1475-2875-8-183","article-title":"MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum","volume":"8","author":"Bergmann-Leitner","year":"2009","journal-title":"Malar J"},{"key":"2019052411105870600_CIT0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4269\/ajtmh.2006.75.437","article-title":"Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens","volume":"75","author":"Bergmann-Leitner","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2019052411105870600_CIT0046","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/IAI.01129-08","article-title":"Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness","volume":"77","author":"Stanisic","year":"2009","journal-title":"Infect Immun"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/12\/1969\/28701094\/jiz027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:18:22Z","timestamp":1720916302000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/12\/1969\/5289319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,1,14]]},"published-print":{"date-parts":[[2019,5,24]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz027","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,15]]},"published":{"date-parts":[[2019,1,14]]}}}